Fundraising Fox

Freddie Dear

Investor

Principal (Portfolio) at Monograph Capital Partners

London

FoundedNocion Therapeutics

About

Principal at Monograph who was part of the founding team of portfolio company Ascend Advanced Therapies and sits on the board of Nocion Therapeutics. Previously an Investment Partner at Syncona and part of the Wellcome Trust investment team.

Experience

  1. Monograph CapitalPrincipalcurrent2024 β€” presentSan Francisco Bay Area
  2. Monograph CapitalPrincipal2021 β€” 2024Greater London, England, United Kingdom
  3. Nocion Therapeutics, Inc.Investor Directorcurrent2024 β€” present
  4. Ascend Advanced TherapiesStrategic Advisorcurrent2024 β€” presentSan Francisco Bay Area
  5. Ascend Advanced TherapiesVP, Corporate Development2024San Francisco Bay Area
  6. Ascend Advanced TherapiesVP, Corporate Development2022 β€” 2024Greater London, England, United Kingdom
  7. Ascend Advanced TherapiesHead of Corporate Development & Portfolio Manager2021 β€” 2022Greater London, England, United Kingdom
  8. Clade TherapeuticsBoard Observer2021
  9. Forcefield TherapeuticsBoard Observer2020 β€” 2021Greater London, England, United Kingdom
  10. Quell TherapeuticsBoard Observer2019 β€” 2021London Area, United Kingdom
  11. Quell TherapeuticsDirector Of Operations2019 β€” 2020London Area, United Kingdom
  12. Syncona LimitedInvestment Partner2018 β€” 2021London Area, United Kingdom
  13. Syncona LimitedSecondee2017 β€” 2018London Area, United Kingdom
  14. Wellcome TrustFinance and Investment graduate2016 β€” 2018London Area, United Kingdom
  15. Tetragon Financial Group LimitedInternship2015London Area, United Kingdom

Education

  1. The University of EdinburghBachelor of Science (BSc), Biochemistry2012 β€” 2016

Same school

Shared employers

Deals Β· 1

Nocion TherapeuticsBoard seat

via Monograph Capital Partners Β· filed Mar 2026 Β· $23M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Monograph Capital Partners